Results 21 to 30 of about 71,483 (285)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial. [PDF]

PLoS Neglected Tropical Diseases, 2018
BACKGROUND:Mass azithromycin distribution reduces under-5 child mortality. Trachoma control programs currently treat infants aged 6 months and older. Here, we report findings from an infant adverse event survey in 1-5 month olds who received azithromycin
Catherine E Oldenburg, Ahmed M Arzika, Ramatou Maliki, Mohamed Salissou Kane, Elodie Lebas, Kathryn J Ray, Catherine Cook, Sun Y Cotter, Zhaoxia Zhou, Sheila K West, Robin Bailey, Travis C Porco, Jeremy D Keenan, Thomas M Lietman, MORDOR Study Group   +14 more
doaj   +1 more source

Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan

Microbiology Spectrum
The latest guidelines include azithromycin as a preferred regimen for treating Mycobacterium avium complex (MAC) pulmonary disease. However, serially collected susceptibility data on clinical MAC isolates are limited, and no breakpoints have been ...
Yoshifumi Uwamino, Wataru Aoki, Rika Inose, Yuka Kamoshita, Kei Mikita, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita, Naoki Hasegawa   +8 more
doaj   +1 more source

Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. [PDF]

PLoS ONE, 2013
ObjectivesTo evaluate therapy for Mycoplasma genitalium infection with doxycycline or azithromycin 1 g compared to five days of azithromycin (total dose 1.5 g).MethodsA retrospective case study was performed among patients attending the STD-clinic in ...
Carin Anagrius, Britta Loré, Jørgen Skov Jensen   +2 more
doaj   +1 more source

Creation of an assessment system for measuring the bitterness of azithromycin-containing reverse micelles

Asian Journal of Pharmaceutical Sciences, 2018
We aimed to develop a novel method for assessing the bitterness of azithromycin-containing reverse micelles (AM-containing RMs). Azithromycin-containing reverse micelles were prepared by processing Lipoid E80 and medium chain triglycerides via a freeze ...
Ri Huang, Yadan Zhang, Tao Wang, Liao Shen, Zhen Zhang, Yang Wang, Dongqin Quan   +6 more
doaj   +1 more source

Azithromycin and the Outcome of Treated COVID-19 Patients: A Hospital-Based Study

Journal of Midwifery, 2022
COVID-19 is an infectious disease that has been declared a pandemic. Currently, there is no validated pharmacological treatment for use in COVID-19 disease and is still in the clinical trial stage.
Elly Usman
doaj   +1 more source

Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial

Malaria Journal, 2021
Background Azithromycin has recently been shown to reduce all-cause childhood mortality in sub-Saharan Africa. One potential mechanism of this effect is via the anti-malarial effect of azithromycin, which may help treat or prevent malaria infection. This
Boubacar Coulibaly, Ali Sié, Clarisse Dah, Mamadou Bountogo, Mamadou Ouattara, Adama Compaoré, Moustapha Nikiema, Jérôme Nankoné Tiansi, Nestor Dembélé Sibiri, Jessica M. Brogdon, Elodie Lebas, Thuy Doan, Travis C. Porco, Thomas M. Lietman, Catherine E. Oldenburg   +14 more
doaj   +1 more source

Azithromycin Prevents Pregnancy Loss: Reducing the Level of Tumor Necrosis Factor-Alpha and Raising the Level of Interleukin-10 in Rats

Mediators of Inflammation, 2013
The aim of this study was to determine the effect of azithromycin on LPS-induced pregnancy loss. Thirty-six pregnant female Wistar rats were divided into 4 equal groups as follows: control group, where 0.3 mL of normal saline solution was administered ...
Ayse Er
doaj   +1 more source

Should azithromycin be used to treat COVID-19? A rapid review

BJGP Open, 2020
Background: There are no established effective treatments for COVID-19. While novel drugs are being developed, azithromycin has been identified as a candidate treatment in the interim.
Kome Gbinigie, Kerstin Frie
doaj   +1 more source

Nanomotion technology for testing azithromycin susceptibility of Salmonella enterica

Microbiology Spectrum
Invasive salmonellosis caused by Salmonella enterica subspecies affects millions of people every year, mostly children from low-income countries, and is associated with a high mortality rate. Azithromycin is used to treat invasive salmonellosis resistant
Mariliis Hinnu, Toomas Mets, Ivana Kerkez, Marta Putrinš, Niilo Kaldalu, Gino Cathomen, Marta Pla Verge, Danuta Cichocka, Alexander Sturm, Tanel Tenson   +9 more
doaj   +1 more source